文献速递妇科

子宫肌瘤栓塞与聚焦超声的围手术期结局比较:一项随机对照试验与综合队列分析

Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.
PubMed 文献 · Am J Obstet Gynecol · 2017-01-05

本研究在3家美国学术医疗中心纳入绝经前症状性子宫肌瘤女性,随机对照试验57例加非随机平行队列34例,采用综合队列设计比较子宫动脉栓塞与磁共振引导聚焦超声术后6周恢复轨迹与不良事件。聚焦超声手术时间更长(405 vs 139分钟),栓塞组术后即刻疼痛更高、阿片类药物与非甾体抗炎药使用更多、恢复时间更长,不良事件发生率和严重程度两组无显著差异。

要点

  • 聚焦超声手术时间显著长于栓塞(平均405 vs 139分钟,P<.001)。
  • 栓塞组术后即刻疼痛中位数5分,高于聚焦超声组的1分(P=.002)。
  • 栓塞组阿片类(75% vs 21%)和非甾体抗炎药(97% vs 67%)使用率均高于聚焦超声组。

核心结论

  • 子宫动脉栓塞患者恢复时间更长且处方药使用更多,而聚焦超声患者治疗时间更长,这些发现在调整基线疼痛水平和肌瘤负荷后仍独立存在。

研究设计与样本

  • 研究为随机对照试验(n=57)加非随机平行队列(n=34)的综合队列设计,在3家美国学术医疗中心纳入绝经前症状性子宫肌瘤女性,共83例接受治疗,75例完成术后日记。

主要发现

  • 聚焦超声手术时间平均405(标准差146)分钟,栓塞为139(标准差44)分钟(P<.001)。
  • 聚焦超声组43例中23例(53%)接受了2个治疗日。
  • 术后即刻自评疼痛中位数(四分位距):栓塞组5(1-7)分,聚焦超声组1(1-4)分(P=.002)。
  • 与聚焦超声组(n=39)相比,栓塞组(n=36)阿片类药物使用率75% vs 21%(P<.001),非甾体抗炎药使用率97% vs 67%(P<.001),中位恢复时间(四分位距):停工天数8(6-14)vs 4(2-7)天(P<.001),恢复正常天数15(10-29)vs 10(10-15)天(P=.02)。
  • 不良事件发生率和严重程度两组无显著差异;49例不良事件中42例(86%)仅需观察或简单处理,无永久后遗症或死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uterine fibroids are a common problem for reproductive-aged women, yet little comparative effectiveness research is available to guide treatment choice. Uterine artery embolization and magnetic resonance imaging-guided focused ultrasound surgery are minimally invasive therapies approved by the US Food and Drug Administration for treating symptomatic uterine fibroids. The Fibroid Interventions: Reducing Symptoms Today and Tomorrow study is the first randomized controlled trial to compare these 2 fibroid treatments. OBJECTIVE: The objective of the study was to summarize treatment parameters and compare recovery trajectory and adverse events in the first 6 weeks after treatment. STUDY DESIGN: Premenopausal women with symptomatic uterine fibroids seen at 3 US academic medical centers were enrolled in the randomized controlled trial (n = 57). Women meeting identical criteria who declined randomization but agreed to study participation were enrolled in a nonrandomized parallel cohort (n = 34). The 2 treatment groups were analyzed by using a comprehensive cohort design. All women undergoing focused ultrasound and uterine artery embolization received the same postprocedure prescriptions, instructions, and symptom diaries for comparison of recovery in the first 6 weeks. Return to work and normal activities, medication use, symptoms, and adverse events were captured with postprocedure diaries. Data were analyzed using the Wilcoxon rank sum test or χ2 test. Multivariable regression was used to adjust for baseline pain levels and fibroid load when comparing opioid medication, adverse events, and recovery time between treatment groups because these factors varied at baseline between groups and could affect outcomes. Adverse events were also collected. RESULTS: Of 83 women in the comprehensive cohort design who underwent treatment, 75 completed postprocedure diaries. Focused ultrasound surgery was a longer procedure than embolization (mean [SD], 405 [146] vs 139 [44] min; P <.001). Of women undergoing focused ultrasound (n = 43), 23 (53%) underwent 2 treatment days. Immediate self-rated postprocedure pain was higher after uterine artery embolization than focused ultrasound (median [interquartile range], 5 [1-7] vs 1 [1-4]; P = .002). Compared with those having focused ultrasound (n = 39), women undergoing embolization (n = 36) were more likely to use outpatient opioid (75% vs 21%; P < .001) and nonsteroidal antiinflammatory medications (97% vs 67%; P < .001) and to have a longer median (interquartile range) recovery time (days off work, 8 [6-14] vs 4 [2-7]; P < .001; days until return to normal, 15 [10-29] vs 10 [10-15]; P = .02). There were no significant differences in the incidence or severity of adverse events between treatment arms; 86% of adverse events (42 of 49) required only observation or nominal treatment, and no events caused permanent sequelae or death. After adjustment for baseline pain and uterine fibroid load, uterine artery embolization was still significantly associated with higher opioid use and longer time to return to work and normal activities (P < .001 for each). Results were similar when restricted to the randomized controlled trial. CONCLUSION: Women undergoing uterine artery embolization have longer recovery times and use more prescription medications, but women undergoing focused ultrasound have longer treatment times. These findings were independent of baseline pain levels and fibroid load.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Barnard EP, AbdElmagied AM, Vaughan LE, et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol. 2017. PMID: 28063909. doi:10.1016/j.ajog.2016.12.177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。